D. B. Calne

5.5k total citations
87 papers, 4.1k citations indexed

About

D. B. Calne is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, D. B. Calne has authored 87 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Neurology, 31 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in D. B. Calne's work include Parkinson's Disease Mechanisms and Treatments (37 papers), Neurological disorders and treatments (30 papers) and Botulinum Toxin and Related Neurological Disorders (14 papers). D. B. Calne is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (37 papers), Neurological disorders and treatments (30 papers) and Botulinum Toxin and Related Neurological Disorders (14 papers). D. B. Calne collaborates with scholars based in Canada, United States and United Kingdom. D. B. Calne's co-authors include Ali Samii, Pramod Pal, M. Sandler, P. K. Thomas, Joseph Tsui, Susan Calne, B. J. Snow, Ann C. Williams, P. F. Teychenne and N.-S. Chu and has published in prestigious journals such as Nature, Science and Brain.

In The Last Decade

D. B. Calne

84 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. B. Calne Canada 37 2.2k 1.4k 564 530 461 87 4.1k
B. J. Snow Canada 23 2.0k 0.9× 1.2k 0.9× 243 0.4× 345 0.7× 231 0.5× 40 2.8k
Sten‐Magnus Aquilonius Sweden 36 2.0k 0.9× 1.3k 1.0× 192 0.3× 674 1.3× 203 0.4× 96 4.0k
Karen J. Kluin United States 27 759 0.3× 720 0.5× 453 0.8× 440 0.8× 686 1.5× 45 2.3k
Hitoshi Shinotoh Japan 31 1.4k 0.7× 1.0k 0.7× 242 0.4× 490 0.9× 209 0.5× 109 3.4k
B. Bergamasco Italy 41 2.4k 1.1× 992 0.7× 243 0.4× 575 1.1× 109 0.2× 167 5.1k
Phillip D. Swanson United States 37 1.7k 0.8× 1.7k 1.2× 139 0.2× 1.4k 2.6× 204 0.4× 98 4.3k
Arthur E. Oakley United Kingdom 35 813 0.4× 916 0.7× 208 0.4× 991 1.9× 378 0.8× 70 3.9k
Roger Pamphlett Australia 34 1.3k 0.6× 414 0.3× 635 1.1× 832 1.6× 388 0.8× 159 3.4k
Sharon Menzies United States 20 936 0.4× 327 0.2× 307 0.5× 813 1.5× 997 2.2× 22 3.6k
J.A. Edwardson United Kingdom 27 457 0.2× 606 0.4× 243 0.4× 722 1.4× 382 0.8× 51 2.7k

Countries citing papers authored by D. B. Calne

Since Specialization
Citations

This map shows the geographic impact of D. B. Calne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. B. Calne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. B. Calne more than expected).

Fields of papers citing papers by D. B. Calne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. B. Calne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. B. Calne. The network helps show where D. B. Calne may publish in the future.

Co-authorship network of co-authors of D. B. Calne

This figure shows the co-authorship network connecting the top 25 collaborators of D. B. Calne. A scholar is included among the top collaborators of D. B. Calne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. B. Calne. D. B. Calne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adams, J. R., André R. Troiano, & D. B. Calne. (2004). Functional imaging in Tourette?s syndrome. Journal of Neural Transmission. 111(10-11). 1495–1506. 11 indexed citations
2.
McDonnell, G V, José Antonio Cabrera-Gómez, D. B. Calne, D. K. B. Li, & Joël Oger. (2003). Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions. Multiple Sclerosis Journal. 9(2). 204–209. 35 indexed citations
3.
Olanow, C. Warren, Paul F. Good, Hitoshi Shinotoh, et al.. (1996). Manganese intoxication in the rhesus monkey. Neurology. 46(2). 492–498. 202 indexed citations
4.
Takahashi, Hirohide, Robert A. Levine, Matthew P. Galloway, et al.. (1994). Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa‐responsive dystonia. Annals of Neurology. 35(3). 354–356. 32 indexed citations
5.
Hammerstad, John P., Katherine Elliott, Edwin Mak, et al.. (1994). Tendon jerks in Parkinson's disease. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 8(1-2). 123–130. 7 indexed citations
6.
Cordes, M., Zbigniew K. Wszołek, Ronald F. Pfeiffer, & D. B. Calne. (1993). Examination of the presynaptic dopaminergic system using positron emission tomography in a famly with autosomal dominant parkinsonism and dementia due to pallido-ponto-nigral degeneration (PPNO). 34(3). 141–145. 6 indexed citations
7.
Uitti, Ryan J. & D. B. Calne. (1993). Pathogenesis of Idiopathic Parkinsonism. European Neurology. 33(1). 6–23. 27 indexed citations
8.
Hammerstad, John P., Brian D. Pate, Kellie A. Hewitt, et al.. (1993). The transport of L‐6‐fluorodopa and its metabolites from blood to cerebrospinal fluid and brain. Annals of Neurology. 34(4). 603–608. 14 indexed citations
9.
Calne, D. B.. (1992). The free radical hypothesis in idiopathic parkinsonism: Evidence against it. Annals of Neurology. 32(6). 799–803. 52 indexed citations
10.
Nygaard, Torbjoern G., Hirohide Takahashi, Gary A. Heiman, et al.. (1992). Long‐term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa‐responsive dystonia. Annals of Neurology. 32(5). 603–608. 73 indexed citations
11.
Calne, D. B.. (1989). Current concepts on the etiology of Parkinson's disease. Movement Disorders. 4(S1). S11–S14. 5 indexed citations
12.
Calne, D. B. & Andrew Lees. (1988). Late Progression of Post-Encephalitic Parkinson's Syndrome. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 15(2). 135–138. 33 indexed citations
13.
Calne, D. B., et al.. (1988). Normality and Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 15(1). 3–4. 10 indexed citations
14.
Tsui, Joseph, Robin D. Fross, Susan Calne, & D. B. Calne. (1987). Local Treatment of Spasmodic Torticollis with Botulinum Toxin. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 14(S3). 533–535. 43 indexed citations
15.
Greenacre, J.K., P. F. Teychenne, Aviva Petrie, et al.. (1976). THE CARDIOVASCULAR EFFECTS OF BROMOCRIPTINE IN PARKINSONISM. British Journal of Clinical Pharmacology. 3(4). 571–574. 30 indexed citations
16.
Clavería, L. E., et al.. (1975). Oxprenolol in Parkinsonism. The Journal of Clinical Pharmacology. 15(1). 66–68. 2 indexed citations
17.
Calne, D. B., et al.. (1973). “On-Off” Phenomena Related to High Plasma Levodopa. BMJ. 2(5867). 641–643. 25 indexed citations
18.
Reid, John L., et al.. (1972). Circulatory Effects of Intravenous Tyramine and Noradrenalin in Parkinsonism. PubMed. 12(11). 465–471. 3 indexed citations
19.
Calne, D. B.. (1971). Parkinsonism—Physiology and Pharmacology. BMJ. 3(5776). 693–697. 11 indexed citations
20.
Calne, D. B., J. Matthew Brennan, A. S. D. Spiers, & G M Stern. (1970). Hypotension Caused by L-Dopa. BMJ. 1(5694). 474–475. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026